Sofosbuvir‐based regimens for the treatment of chronic hepatitis C in severe renal dysfunction

Sofosbuvir (SOF) is a nonstructural 5B polymerase inhibitor with activity in all hepatitis C virus (HCV) genotypes and is the backbone of many anti‐HCV drug regimens. SOF is converted into inactive metabolites that undergo renal excretion. Patients with an estimated glomerular filtration rate (eGFR)...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Hepatol Commun
Autors principals: Cox‐North, Paula, Hawkins, Kelsey L., Rossiter, Sean T., Hawley, Marie N., Bhattacharya, Renuka, Landis, Charles S.
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2017
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5721450/
https://ncbi.nlm.nih.gov/pubmed/29404457
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep4.1035
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars